Shelli F Farhadian1,2, Danielle Seilhean3, Serena Spudich2. 1. Department of Medicine, Section of Infectious Disease, Yale School of Medicine. 2. Department of Neurology, Division of Neurological Infections and Global Neurology, Yale School of Medicine, New Haven, Connecticut, USA. 3. Department of Neuropathology, Sorbonne University, Paris, France.
Abstract
PURPOSE OF REVIEW: Over the course of the coronavirus disease (COVID-19) pandemic, it has become increasingly clear that there is a high prevalence of neurological complications in people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). RECENT FINDINGS: Studies of central nervous system (CNS) tissue in brain model systems and from adults with acute SARS-CoV-2 infection have begun to uncover potential mechanisms for neurological damage during COVID-19. These studies suggest that direct viral invasion of the CNS occurs in a subset of cases but does not frequently cause overt viral meningoencephalitis. Vascular abnormalities including microvascular thrombi and endothelial activation, as well as parainfectious processes, including CNS specific immune responses, may contribute to neurological symptoms during acute SARS-CoV-2 infection. SUMMARY: Neuroimmune perturbations and vascular inflammation observed in people with COVID-19 may warrant investigation of immune-modulating interventions to ameliorate neurological complications associated with acute SARS-CoV-2 infection. These therapies may also impact the trajectory of potential long-term complications of COVID-19.
PURPOSE OF REVIEW: Over the course of the coronavirus disease (COVID-19) pandemic, it has become increasingly clear that there is a high prevalence of neurological complications in people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). RECENT FINDINGS: Studies of central nervous system (CNS) tissue in brain model systems and from adults with acute SARS-CoV-2 infection have begun to uncover potential mechanisms for neurological damage during COVID-19. These studies suggest that direct viral invasion of the CNS occurs in a subset of cases but does not frequently cause overt viral meningoencephalitis. Vascular abnormalities including microvascular thrombi and endothelial activation, as well as parainfectious processes, including CNS specific immune responses, may contribute to neurological symptoms during acute SARS-CoV-2 infection. SUMMARY: Neuroimmune perturbations and vascular inflammation observed in people with COVID-19 may warrant investigation of immune-modulating interventions to ameliorate neurological complications associated with acute SARS-CoV-2 infection. These therapies may also impact the trajectory of potential long-term complications of COVID-19.
Authors: Lauren A Beslow; Shannon C Agner; Jonathan D Santoro; Dipak Ram; Jenny L Wilson; Dana Harrar; Brian Appavu; Stuart M Fraser; Thomas Rossor; Marcela D Torres; Manoëlle Kossorotoff; Yenny C Zuñiga Zambrano; Marta Hernández-Chávez; Sahar M A Hassanein; Dimitrios Zafeiriou; Michael M Dowling; Ilona Kopyta; Nicholas V Stence; Timothy J Bernard; Nomazulu Dlamini Journal: Stroke Date: 2022-04-05 Impact factor: 10.170
Authors: Steve Reiken; Leah Sittenfeld; Haikel Dridi; Yang Liu; Xiaoping Liu; Andrew R Marks Journal: Alzheimers Dement Date: 2022-02-03 Impact factor: 21.566